Type of Posting: Revision Bulletin
Posting Date: 29–Dec–2011
Official Date: 01–Feb–2012
Expert Committee: General Chapters—Dosage Forms
Reason for Revision: Compliance
In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the General Chapters—Dosage Forms Expert Committee has revised General Chapter <711> Dissolution. The purpose for the revision is to remove Chlorpheniramine Maleate Extended-Release Tablets RS from the list of reference standards and from the Apparatus Suitability section. The revision is necessitated by the depletion of the current lot of Chlorpheniramine Maleate Extended-Release Tablets RS and the lack of a replacement lot. USP is in the process of identifying a replacement material that will be suitable to use in the Performance Verification Test for Apparatus 3.
The General Chapter <711> Dissolution Revision Bulletin supersedes the currently official General Chapter <711> Dissolution. The Revision Bulletin will be incorporated in the Second Supplement to USP 35–NF 30.
Should you have any questions, please contact William E. Brown (301-816-8380 or web@usp.org).